Listed

Spruce Biosciences, Inc.

SPRBNasdaqCIK 1683553HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2025
Operating income−$16.5m, Q2 FY2026
Net income−$16.2m, Q2 FY2026
Spruce Biosciences, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m3.1Revenue, Q3 FY2023, three months to 2023-09-30$3.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure2.9Revenue, Q4 FY2023, three months to 2023-12-31$2.9m. XBRL concept us-gaap:Revenues. 10-K filed 2025-04-15, accession 0000950170-25-053945. Derived: 12-month figure less the 9-month figure.Report this figure2.0Revenue, Q1 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure1.6Revenue, Q2 FY2024, three months to 2024-06-30$1.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure0.6Revenue, Q3 FY2024, three months to 2024-09-30$602.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure0.7Revenue, Q4 FY2024, three months to 2024-12-31$697.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Research and development$m13.5Research and development, Q3 FY2023, three months to 2023-09-30$13.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure11.1Research and development, Q4 FY2023, three months to 2023-12-31$11.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-04-15, accession 0000950170-25-053945. Derived: 12-month figure less the 9-month figure.Report this figure10.3Research and development, Q1 FY2024, three months to 2024-03-31$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure8.1Research and development, Q2 FY2024, three months to 2024-06-30$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure6.6Research and development, Q3 FY2024, three months to 2024-09-30$6.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure21.5Research and development, Q4 FY2024, three months to 2024-12-31$21.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure10.8Research and development, Q1 FY2025, three months to 2025-03-31$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(0.4)Research and development, Q2 FY2025, three months to 2025-06-30−$430.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure5.0Research and development, Q3 FY2025, three months to 2025-09-30$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure4.1Research and development, Q4 FY2025, three months to 2025-12-31$4.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure7.6Research and development, Q1 FY2026, three months to 2026-03-31$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure12.2Research and development, Q2 FY2026, three months to 2026-06-30$12.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Operating income$m(13.7)Operating income, Q3 FY2023, three months to 2023-09-30−$13.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure(11.2)Operating income, Q4 FY2023, three months to 2023-12-31−$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-04-15, accession 0000950170-25-053945. Derived: 12-month figure less the 9-month figure.Report this figure(12.6)Operating income, Q1 FY2024, three months to 2024-03-31−$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure(10.0)Operating income, Q2 FY2024, three months to 2024-06-30−$10.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure(9.4)Operating income, Q3 FY2024, three months to 2024-09-30−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure(24.1)Operating income, Q4 FY2024, three months to 2024-12-31−$24.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure(14.5)Operating income, Q1 FY2025, three months to 2025-03-31−$14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(2.7)Operating income, Q2 FY2025, three months to 2025-06-30−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure(8.2)Operating income, Q3 FY2025, three months to 2025-09-30−$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure(11.1)Operating income, Q4 FY2025, three months to 2025-12-31−$11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure(12.0)Operating income, Q1 FY2026, three months to 2026-03-31−$12.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(16.5)Operating income, Q2 FY2026, three months to 2026-06-30−$16.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$119.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure0.1Interest expense, Q4 FY2023, three months to 2023-12-31$106.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-04-15, accession 0000950170-25-053945. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2024, three months to 2024-03-31$97.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure0.1Interest expense, Q2 FY2024, three months to 2024-06-30$83.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure0.1Interest expense, Q3 FY2024, three months to 2024-09-30$71.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-12-31$56.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$36.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$29.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$19.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$6.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure0.7Interest expense, Q1 FY2026, three months to 2026-03-31$674.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure1.1Interest expense, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Net income$m(12.4)Net income, Q3 FY2023, three months to 2023-09-30−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure(10.0)Net income, Q4 FY2023, three months to 2023-12-31−$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-04-15, accession 0000950170-25-053945. Derived: 12-month figure less the 9-month figure.Report this figure(11.6)Net income, Q1 FY2024, three months to 2024-03-31−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure(9.2)Net income, Q2 FY2024, three months to 2024-06-30−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure(8.7)Net income, Q3 FY2024, three months to 2024-09-30−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure(23.6)Net income, Q4 FY2024, three months to 2024-12-31−$23.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure(14.0)Net income, Q1 FY2025, three months to 2025-03-31−$14.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(2.1)Net income, Q2 FY2025, three months to 2025-06-30−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure(8.2)Net income, Q3 FY2025, three months to 2025-09-30−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure(14.6)Net income, Q4 FY2025, three months to 2025-12-31−$14.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure(12.3)Net income, Q1 FY2026, three months to 2026-03-31−$12.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(16.2)Net income, Q2 FY2026, three months to 2026-06-30−$16.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Diluted EPS$ per share(0.30)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figurenot reported(0.28)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure(16.73)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$16.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure(15.75)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$15.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figurenot reported(23.95)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$23.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(3.50)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$3.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure(14.58)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$14.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figurenot reported(8.94)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$8.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(6.68)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$6.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Basic EPS$ per share(0.30)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figurenot reported(0.28)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure(16.73)Basic EPS, Q2 FY2024, three months to 2024-06-30−$16.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure(15.75)Basic EPS, Q3 FY2024, three months to 2024-09-30−$15.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figurenot reported(23.95)Basic EPS, Q1 FY2025, three months to 2025-03-31−$23.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(3.50)Basic EPS, Q2 FY2025, three months to 2025-06-30−$3.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure(14.58)Basic EPS, Q3 FY2025, three months to 2025-09-30−$14.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figurenot reported(8.94)Basic EPS, Q1 FY2026, three months to 2026-03-31−$8.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(6.68)Basic EPS, Q2 FY2026, three months to 2026-06-30−$6.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure

Balance sheet

Cash and equivalents$96.3m, Q2 FY2026
Long-term debt$4.6m, Q2 FY2026
Shareholders' equity$83.7m, Q2 FY2026
Spruce Biosciences, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m98.8Cash and equivalents, Q3 FY2023, at 2023-09-30$98.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure96.3Cash and equivalents, FY2023, at 2023-12-31$96.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-04-15, accession 0000950170-25-053945.Report this figure81.2Cash and equivalents, Q1 FY2024, at 2024-03-31$81.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure69.7Cash and equivalents, Q2 FY2024, at 2024-06-30$69.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure60.1Cash and equivalents, Q3 FY2024, at 2024-09-30$60.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure38.8Cash and equivalents, FY2024, at 2024-12-31$38.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001193125-26-097558.Report this figure25.6Cash and equivalents, Q1 FY2025, at 2025-03-31$25.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure16.4Cash and equivalents, Q2 FY2025, at 2025-06-30$16.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure10.7Cash and equivalents, Q3 FY2025, at 2025-09-30$10.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure48.9Cash and equivalents, FY2025, at 2025-12-31$48.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure54.1Cash and equivalents, Q1 FY2026, at 2026-03-31$54.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure96.3Cash and equivalents, Q2 FY2026, at 2026-06-30$96.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Current assets$m111Current assets, Q3 FY2023, at 2023-09-30$111.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062997.Report this figure102Current assets, FY2023, at 2023-12-31$102.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-04-15, accession 0000950170-25-053945.Report this figure85.9Current assets, Q1 FY2024, at 2024-03-31$85.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058657.Report this figure73.9Current assets, Q2 FY2024, at 2024-06-30$73.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095461.Report this figure63.6Current assets, Q3 FY2024, at 2024-09-30$63.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure44.2Current assets, FY2024, at 2024-12-31$44.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001193125-26-097558.Report this figure30.6Current assets, Q1 FY2025, at 2025-03-31$30.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure21.0Current assets, Q2 FY2025, at 2025-06-30$21.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure14.5Current assets, Q3 FY2025, at 2025-09-30$14.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure52.1Current assets, FY2025, at 2025-12-31$52.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure55.0Current assets, Q1 FY2026, at 2026-03-31$55.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure101Current assets, Q2 FY2026, at 2026-06-30$101.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Total assets$m113Total assets, Q3 FY2023, at 2023-09-30$113.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0000950170-23-062997.Report this figure104Total assets, FY2023, at 2023-12-31$103.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-04-15, accession 0000950170-25-053945.Report this figure87.5Total assets, Q1 FY2024, at 2024-03-31$87.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0000950170-24-058657.Report this figure75.5Total assets, Q2 FY2024, at 2024-06-30$75.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0000950170-24-095461.Report this figure65.1Total assets, Q3 FY2024, at 2024-09-30$65.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure45.2Total assets, FY2024, at 2024-12-31$45.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001193125-26-097558.Report this figure31.6Total assets, Q1 FY2025, at 2025-03-31$31.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure21.8Total assets, Q2 FY2025, at 2025-06-30$21.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure15.3Total assets, Q3 FY2025, at 2025-09-30$15.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure53.0Total assets, FY2025, at 2025-12-31$53.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure56.2Total assets, Q1 FY2026, at 2026-03-31$56.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure103Total assets, Q2 FY2026, at 2026-06-30$102.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Current liabilities$m24.2Current liabilities, Q3 FY2023, at 2023-09-30$24.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062997.Report this figure24.5Current liabilities, FY2023, at 2023-12-31$24.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-04-15, accession 0000950170-25-053945.Report this figure18.4Current liabilities, Q1 FY2024, at 2024-03-31$18.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058657.Report this figure14.3Current liabilities, Q2 FY2024, at 2024-06-30$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095461.Report this figure11.9Current liabilities, Q3 FY2024, at 2024-09-30$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure15.2Current liabilities, FY2024, at 2024-12-31$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001193125-26-097558.Report this figure15.7Current liabilities, Q1 FY2025, at 2025-03-31$15.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure8.1Current liabilities, Q2 FY2025, at 2025-06-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure9.4Current liabilities, Q3 FY2025, at 2025-09-30$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure10.1Current liabilities, FY2025, at 2025-12-31$10.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure11.8Current liabilities, Q1 FY2026, at 2026-03-31$11.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure11.0Current liabilities, Q2 FY2026, at 2026-06-30$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Total liabilities$m27.6Total liabilities, Q3 FY2023, at 2023-09-30$27.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0000950170-23-062997.Report this figure27.4Total liabilities, FY2023, at 2023-12-31$27.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-04-15, accession 0000950170-25-053945.Report this figure20.9Total liabilities, Q1 FY2024, at 2024-03-31$20.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0000950170-24-058657.Report this figure16.4Total liabilities, Q2 FY2024, at 2024-06-30$16.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0000950170-24-095461.Report this figure13.5Total liabilities, Q3 FY2024, at 2024-09-30$13.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure16.4Total liabilities, FY2024, at 2024-12-31$16.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001193125-26-097558.Report this figure16.3Total liabilities, Q1 FY2025, at 2025-03-31$16.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure8.6Total liabilities, Q2 FY2025, at 2025-06-30$8.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure9.9Total liabilities, Q3 FY2025, at 2025-09-30$9.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure10.5Total liabilities, FY2025, at 2025-12-31$10.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure21.5Total liabilities, Q1 FY2026, at 2026-03-31$21.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure19.1Total liabilities, Q2 FY2026, at 2026-06-30$19.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Long-term debt$m2.1Long-term debt, Q3 FY2023, at 2023-09-30$2.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062997.Report this figure1.7Long-term debt, FY2023, at 2023-12-31$1.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-04-15, accession 0000950170-25-053945.Report this figure1.3Long-term debt, Q1 FY2024, at 2024-03-31$1.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058657.Report this figure0.9Long-term debt, Q2 FY2024, at 2024-06-30$923.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095461.Report this figure0.5Long-term debt, Q3 FY2024, at 2024-09-30$524.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure0.1Long-term debt, FY2024, at 2024-12-31$124.0k. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-09, accession 0001193125-26-097558.Report this figure0.0Long-term debt, Q1 FY2025, at 2025-03-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure0.0Long-term debt, Q2 FY2025, at 2025-06-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure0.0Long-term debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure0.0Long-term debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure5.5Long-term debt, Q1 FY2026, at 2026-03-31$5.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure4.6Long-term debt, Q2 FY2026, at 2026-06-30$4.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Current portion of debt$m1.6Current portion of debt, Q3 FY2023, at 2023-09-30$1.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-062997.Report this figure1.6Current portion of debt, FY2023, at 2023-12-31$1.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-04-15, accession 0000950170-25-053945.Report this figure1.6Current portion of debt, Q1 FY2024, at 2024-03-31$1.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058657.Report this figure1.6Current portion of debt, Q2 FY2024, at 2024-06-30$1.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095461.Report this figure1.6Current portion of debt, Q3 FY2024, at 2024-09-30$1.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure1.6Current portion of debt, FY2024, at 2024-12-31$1.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-09, accession 0001193125-26-097558.Report this figure1.3Current portion of debt, Q1 FY2025, at 2025-03-31$1.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure0.9Current portion of debt, Q2 FY2025, at 2025-06-30$943.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure0.5Current portion of debt, Q3 FY2025, at 2025-09-30$539.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure1.0Current portion of debt, Q1 FY2026, at 2026-03-31$1.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure2.5Current portion of debt, Q2 FY2026, at 2026-06-30$2.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure
Shareholders' equity$m85.4Shareholders' equity, Q3 FY2023, at 2023-09-30$85.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure76.5Shareholders' equity, FY2023, at 2023-12-31$76.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001193125-26-097558.Report this figure66.6Shareholders' equity, Q1 FY2024, at 2024-03-31$66.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure59.2Shareholders' equity, Q2 FY2024, at 2024-06-30$59.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure51.6Shareholders' equity, Q3 FY2024, at 2024-09-30$51.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure28.8Shareholders' equity, FY2024, at 2024-12-31$28.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure15.3Shareholders' equity, Q1 FY2025, at 2025-03-31$15.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure13.2Shareholders' equity, Q2 FY2025, at 2025-06-30$13.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure5.4Shareholders' equity, Q3 FY2025, at 2025-09-30$5.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure42.5Shareholders' equity, FY2025, at 2025-12-31$42.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure34.6Shareholders' equity, Q1 FY2026, at 2026-03-31$34.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure83.7Shareholders' equity, Q2 FY2026, at 2026-06-30$83.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure

Cash flow

Operating cash flow−$22.1m, Q2 FY2026
Capital expenditure$135.0k, Q2 FY2026
Spruce Biosciences, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(12.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-124479. Derived: 9-month figure less the 6-month figure.Report this figure(11.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$11.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-04-15, accession 0000950170-25-053945. Derived: 12-month figure less the 9-month figure.Report this figure(15.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure(11.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$11.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108888. Derived: 6-month figure less the 3-month figure.Report this figure(9.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274234. Derived: 9-month figure less the 6-month figure.Report this figure(20.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$20.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure(12.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$12.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(8.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$8.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345876. Derived: 6-month figure less the 3-month figure.Report this figure(5.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274234. Derived: 9-month figure less the 6-month figure.Report this figure(6.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001193125-26-097558. Derived: 12-month figure less the 9-month figure.Report this figure(8.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure(22.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$22.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345876. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-124479. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-04-15, accession 0000950170-25-053945. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reported0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-04-15, accession 0000950170-25-053945. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-345876. Derived: 6-month figure less the 3-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$135.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-345876. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)2.43m, Q2 FY2026
Spruce Biosciences, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares23.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3023,560,250 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0000950170-23-062997.Report this figure31.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3131,900,160 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0000950170-24-058657.Report this figure40.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3040,547,925 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0000950170-24-095461.Report this figure40.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3040,710,692 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-124479.Report this figure41.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3141,096,231 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-064463.Report this figure0.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30548,789 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108888.Report this figure0.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30550,645 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure0.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31586,142 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure0.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30591,137 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure0.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30563,066 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274234.Report this figure1.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,372,084 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-221605.Report this figure2.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-302,431,075 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure

Shares outstanding: 2.87mShares outstanding, period not labelled, at 2026-08-102,874,013 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345876.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.